COMMUNIQUÉS West-GlobeNewswire

Tonix Pharmaceuticals Reports Second Quarter 2018 Financial Results and Operational Highlights
13/08/2018
HONOR Study Results to be Included in Poster Presentation at a Scientific Conference in August 2018 FDA Meeting in October 2018 Confirmed to Discuss New Phase 3 Study for Tonmya® in PTSD New Phase 3 Study for Tonmya May [...]
Zealand hosts conference call on August 16 at 4 pm CET/10 am EDT to present first half of 2018 results
13/08/2018
Press Release - No. 18 / 2018 Zealand hosts conference call on August 16 at 4 pm CET/10 am EDT to present first half of 2018 results Copenhagen, August 13, 2018 - Zealand Pharma A/S ("Zealand") (CVR no. 20 04 50 78) [...]
Stemline Therapeutics Announces that FDA Accepts ELZONRIS™ Biologics License Application (BLA) and Grants Priority Review
13/08/2018
Conference call on BLA acceptance and commercial readiness scheduled for Monday, August 13, 2018 at 8:30 AM ET NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a clinical-stage [...]
Nightstar Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights
13/08/2018
Regenerative Medicine Advanced Therapy (RMAT) Designation received in June 2018 for NSR-REP1 in Choroideremia Preliminary data from Phase 1/2 XIRIUS trial for X-Linked Retinitis Pigmentosa expected at EURETINA 2018 in [...]
Adherium Launches Hailie™ Solution Direct-to-Consumer in the U.S. for Better Asthma and COPD Management
13/08/2018
SAN MATEO, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX: ADR), a leading digital health platform that focuses on improving medication adherence and patient outcomes, today officially launched the Hailie™ [...]
Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results
13/08/2018
Publication of PEDMARK TM SIOPEL 6 Clinical Data in The New England Journal of Medicine Joined Russell 3000 Index Strong financial position with $25.6 million in cash and no debt RESEARCH TRIANGLE PARK, N.C., Aug. 13, [...]
Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain
13/08/2018
Sunnyvale, Aug. 13, 2018 (GLOBE NEWSWIRE) -- August 13, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, has been approved for in-store allergy testing [...]
1st Patient Treated for Osteoarthritis Knee Pain in Sorrento Resiniferatoxin Phase 1B Trial Meets Both Safety and Efficacy Expectations
13/08/2018
SAN DIEGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced that the first enrolled patient in the phase 1b study of its non-opioid, afferent nerve ablating drug [...]
Immunicum AB (publ) to Present Preclinical Data on Ilixadencel in Combination with CPIs and Immune Enhancers at ESMO 2018 Congress
13/08/2018
Press Release 13 August 2018 Immunicum AB (publ) to Present Preclinical Data on Ilixadencel in Combination with CPIs and Immune Enhancers at ESMO 2018 Congress Immunicum AB (publ; IMMU.ST) announced today that the [...]
New Drug Application Submitted in Japan for INTUNIV® (guanfacine hydrochloride extended release) in Adults with ADHD
13/08/2018
New Drug Application Submitted in Japan for INTUNIV ® (guanfacine hydrochloride extended release) in Adults with ADHD Shire’s partner, Shionogi, filed application to expand INTUNIV ® indication in Japan to include [...]
Basilea reports on first Cresemba® approval in MENA region
13/08/2018
Basel, Switzerland, August 13, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Hikma Pharmaceuticals LLC, gained regulatory approval for the antifungal Cresemba ® (isavuconazole) in Jordan [...]
First Patient Imaged in Prostate Imaging Study
13/08/2018
MELBOURNE, Australia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“ Telix ”, the “ Company ”), an Australian biopharmaceutical company focused on the development of diagnostic and [...]
Loxo Oncology Announces Accepted Abstracts at the IASLC 19th World Conference on Lung Cancer
10/08/2018
STAMFORD, Conn., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, today announced that [...]
OrthoPediatrics Corp. to Present at FDA Conference on Pediatric Devices
10/08/2018
WARSAW, Ind., Aug. 10, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to participate in the Pediatric Medical [...]
FDA Approves Galafold™ (migalastat) for the Treatment of Certain Adult Patients with Fabry Disease
10/08/2018
First Precision and First Oral Medicine for Fabry Disease Approved for 348 Amenable GLA Variants Galafold is the First New Treatment Option for Fabry Disease in the U.S. in 15+ Years Amicus Therapeutics to Host [...]
Sientra Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/08/2018
SANTA BARBARA, Calif., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq:SIEN) (the “Company”) today announced that on August 8, 2018, Paul Little received an equity award grant from the Compensation Committee of [...]
Novo Nordisk A/S - Share repurchase programme
10/08/2018
Bagsværd, Denmark, 10 August 2018 - As part of the up to DKK 14 billion 2018 share repurchase programme, Novo Nordisk A/S has now initiated a new share repurchase programme for an amount of up to DKK 2.4 billion in [...]
Novo Nordisk A/S purchases B shares worth DKK 954 million from Novo Holdings A/S under the 2018 share repurchase programme
10/08/2018
Bagsværd, Denmark, 10 August 2018 - Novo Nordisk A/S has today entered into an agreement to purchase 3,120,644 B shares (nominal DKK 0.20) of a value of DKK 954 million from Novo Holdings A/S. This transaction is part [...]
Abeona Therapeutics annonce ses résultats financiers du deuxième trimestre 2018 et les faits saillants de la société
10/08/2018
Conférence téléphonique des investisseurs le vendredi 10 août à 10h00 (heure de l’Est) NEW YORK et CLEVELAND, 10 août 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), une société biopharmaceutique de [...]

Pages